The Morbidity, Recovery and Survivorship Working Committee provides scientific oversight for studies related to preparative regimens, prevention and treatment of early non-Graft-versus-Host Disease toxicities and supportive care in the early post-HCT/cellular therapy period as well as studies regarding issues of long-term survivors of HCT and other cellular therapies, including clinical and psychosocial effects.
Annie Im
University of Pittsburgh Medical Center - Cancer Center
Pittsburgh, PA
Sairah Ahmed
M.D. Anderson Cancer Center
Houston, TX
Seth Rotz
Cleveland Clinic Foundation
Cleveland, OH
Ruta Brazauskas
CIBMTR - Milwaukee
Milwaukee, WI
Amy Moskop
Rachel Phelan
Andrew Peterson